Twelve Bio

Exited

Advancing CRISPR gene editing technology

Twelve Bio is tracked in the Tech.eu funding database. Based in Copenhagen, Denmark; active in Healthtech. Acquired by Ensoma in 2023. Data as of 27 Aug 2026.

Copenhagen, Denmarktwelve.bio ↗

Healthtech

← All companies

Total raised

€0

Funding rounds

Investors

distinct backers

Active since

—

Funding rounds

0 rounds

No funding rounds recorded.

Exit

Type

acquisition

Date

Jan 2023

Value

—

Acquiror

Ensoma (United States of America)

Similar companies

same sector or country

Philips
Netherlands · Healthtech

Twelve Bio

Funding rounds

Exit

Related news

Similar companies